Joachim Riethmüller
-
- Cystic Fibrosis Research Advances 30
- Inhalation and Respiratory Drug Delivery 10
- Neonatal Respiratory Health Research 10
- Molecular Medicine top 5%
- Molecular Biology top 5%
- Sphingolipid Metabolism and Signaling 8
- Bacterial biofilms and quorum sensing 4
- Lipid Membrane Structure and Behavior 3
- Endocrinology top 5%
- Otorhinolaryngology top 5%
- Sinusitis and nasal conditions 5
-
- Pneumonia and Respiratory Infections 6
Joachim Riethmüller
45 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Medicine 134
- Molecular Biology 1.5k
- Endocrinology 98
- Otorhinolaryngology 83
Countries citing papers authored by Joachim Riethmüller
This map shows the geographic impact of Joachim Riethmüller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Riethmüller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Riethmüller more than expected).
Fields of papers citing papers by Joachim Riethmüller
This network shows the impact of papers produced by Joachim Riethmüller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Riethmüller. The network helps show where Joachim Riethmüller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joachim Riethmüller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 20 | |
| 2 | 2018 | 64 | |
| 3 | 2018 | 16 | |
| 4 | 2018 | 28 | |
| 5 | 2017 | 27 | |
| 6 | 2017 | 87 | |
| 7 | 2016 | 12 | |
| 8 | 2016 | 84 | |
| 9 | 2016 | 22 | |
| 10 | 2015 | 45 | |
| 11 | 2014 | 14 | |
| 12 | Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Studybreakdown → | 2013 | 1203 |
| 13 | 2011 | 11 | |
| 14 | 2010 | 18 | |
| 15 | 2010 | 169 | |
| 16 | 2010 | 11 | |
| 17 | 2008 | 460 | |
| 18 | 2000 | 9 | |
| 19 | 1997 | 49 | |
| 20 | 1992 | 52 |
About Joachim Riethmüller
Joachim Riethmüller is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Molecular Medicine, having authored 46 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (30 papers), Inhalation and Respiratory Drug Delivery (10 papers), Neonatal Respiratory Health Research (10 papers), Sphingolipid Metabolism and Signaling (8 papers), Pneumonia and Respiratory Infections (6 papers), Sinusitis and nasal conditions (5 papers), Bacterial biofilms and quorum sensing (4 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Molecular Medicine (134 citations) and Molecular Biology (1.5k citations). Joachim Riethmüller has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Erich Gulbins, Gerd Döring, Heike Grassmé, Gloria Herrmann, Ute Graepler-Mainka, Jochen G. Mainz, S. Heyder, Corinna Engel, Andreas Hector and Constantin Adams. Their work appears in journals such as Nature Medicine, The Journal of Immunology and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.